Core Viewpoint - The 8th China International Import Expo (CIIE) highlights the commitment of multinational companies like Shiseido and Bayer to invest in the Chinese market, emphasizing innovation and collaboration as key drivers for sustainable development and high-quality growth in the beauty and life sciences sectors [1][2]. Group 1: Shiseido's Participation - Shiseido's CEO, Masahiro Matsumoto, expressed confidence in the Chinese market, stating that the company's commitment to beauty innovation aligns with the open spirit promoted by the CIIE [1]. - Shiseido has participated in the CIIE for seven consecutive years, evolving from a mere exhibitor to a proactive collaborator, integrating global R&D capabilities with local insights [1]. - The launch of Shiseido's new brand 'RQ PYOLOGY' and its product '律曜' exemplifies the successful fusion of global expertise and local consumer needs [1]. Group 2: Bayer's Commitment - Bayer's Chairman, Bill Anderson, highlighted the unique opportunities presented by the CIIE, emphasizing the company's dedication to serving patients, consumers, and growers in China and globally [1]. - Anderson pointed out that China is a crucial strategic pillar for Bayer, with the company continuously investing in innovation and collaboration to address pressing challenges such as population growth, aging, and climate change [1]. - Bayer has initiated several new projects in the past year, reflecting its commitment to industry upgrades and alignment with China's high-quality development vision [1].